News related to Enbrel (Etanercept) and/or conditions it is approved for
Case Study: PBC Responds to Anti-TNF Agent (CME/CE)
Source: MedPage Today Gastroenterology [2015.08.25]
(MedPage Today) -- Symptoms abated after Enbrel started, and returned when it was stopped
Amgen to pay $71 million over allegations of unlawfully marketing biologic medications
Source: Pharma Industry / Biotech Industry News From Medical News Today [2015.08.20]
Resolving allegations that it unlawfully promoted biologic medications Aranesp and Enbrel for uses not approved by the U.S. Food and Drug Administration (FDA), Amgen, Inc.